Citation 105418

COS,P: YING,L: CALOMME,M: HU,JP: CIMANGA,K: POEL,BV: PIETERS,L: VLIETINCK,AJ: BERGHE,DV:. (1998). STRUCTURE-ACTIVITY RELATIONSHIP AND CLASSIFICATION OF FLAVONOIDS AS INHIBITORS OF XANTHINE OXIDASE AND SUPEROXIDE SCAVENGERS.. 61(1)

Citation Details

Title	STRUCTURE-ACTIVITY RELATIONSHIP AND CLASSIFICATION OF FLAVONOIDS AS INHIBITORS OF XANTHINE OXIDASE AND SUPEROXIDE SCAVENGERS.
Authors	COS,P: YING,L: CALOMME,M: HU,JP: CIMANGA,K: POEL,BV: PIETERS,L: VLIETINCK,AJ: BERGHE,DV:
Year	1998
Volume	61
Issue	1

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN,(DL):	INACTIVE
2	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN,(DL):	ACTIVE
3	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
4	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
5	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	INACTIVE
6	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	ACTIVE
7	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN,EPI: (-):	INACTIVE
8	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN,EPI: (-):	ACTIVE
9	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,4'-HYDROXY:	WEAK ACTIVITY
10	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,4'-HYDROXY:	WEAK ACTIVITY
11	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	WEAK ACTIVITY
12	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	WEAK ACTIVITY
13	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,7-HYDROXY:	WEAK ACTIVITY
14	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,7-HYDROXY:	INACTIVE
15	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	ACTIVE
16	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	ACTIVE
17	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
18	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
19	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
20	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
21	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BAICALEIN	ACTIVE
22	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BAICALEIN	ACTIVE
23	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-HYDROXY:	INACTIVE
24	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-HYDROXY:	INACTIVE
25	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALANGIN	ACTIVE
26	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GALANGIN	WEAK ACTIVITY
27	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
28	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
29	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
30	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
31	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
32	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
33	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	WEAK ACTIVITY
34	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	WEAK ACTIVITY
35	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	ACTIVE
36	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	ACTIVE
37	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN,6-GLUCOSYL-8-XYLOSYL:	INACTIVE
38	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN,6-GLUCOSYL-8-XYLOSYL:	INACTIVE
39	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN,8-GLUCOSYL-6-XYLOSYL:	INACTIVE
40	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN,8-GLUCOSYL-6-XYLOSYL:	INACTIVE
41	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CIRSIMARIN	INACTIVE
42	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CIRSIMARIN	INACTIVE
43	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SAPONARIN	INACTIVE
44	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	SAPONARIN	INACTIVE
45	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN,3'-METHYL-7-NEO-HESPERIDOSYL:	INACTIVE
46	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN,3'-METHYL-7-NEO-HESPERIDOSYL:	INACTIVE
47	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN,7-NEO-HESPERIDOSYL:	WEAK ACTIVITY
48	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN,7-NEO-HESPERIDOSYL:	ACTIVE
49	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TILIROSIDE	INACTIVE
50	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	TILIROSIDE	INACTIVE
51	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL,3-RUTINOSYL:	WEAK ACTIVITY
52	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL,3-RUTINOSYL:	ACTIVE
53	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	WEAK ACTIVITY
54	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	WEAK ACTIVITY
55	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN	INACTIVE
56	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN	WEAK ACTIVITY
57	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN,4'-7-DIMETHYL:	WEAK ACTIVITY
58	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN,4'-7-DIMETHYL:	ACTIVE
59	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN,ISO:	ACTIVE
60	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN,ISO:	ACTIVE
61	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NOBILETIN	INACTIVE
62	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	NOBILETIN	INACTIVE
63	XANTHINE OXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TANGERETIN	INACTIVE
64	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	TANGERETIN	INACTIVE

Citation 105418

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1